Nebraska reportable disease regulations
were updated January 1, 2017 to include the organisms listed below. Reporting enables DHHS to monitor susceptibility patterns in order to detect concerning resistance patterns and identify and control outbreaks.
Required to be reported immediately:
Applies only to laboratories reporting electronically:
- Enterococcus species
Emerging Resistant Organisms
The HAI Program monitors for reports of emerging resistant organisms, including:
All carbapenem resistant Enterobacteriaceae (CREs)
Colistin resistant Acinetobacter (mcr-1 gene)
Staphylococcus aureus, vancomycin-intermediate/resistant
Carbapenem Resistant Organisms
Bacteria that develop resistance to the carbapenem class (doripenem, ertapenem, imipenem, meropenem) of antibiotics represent a concerning group of emerging pathogens. CDC notes that Carbapenem Resistant Enterobacteriaceae (CRE) are an important cause of invasive infections and are often associated with high mortality rates, up to 50%. CRE bacteria have been found in most of the U.S. and are primarily associated with exposure to the healthcare system. CRE has the potential to spread in the community.
In accordance with Nebraska Title 173 Chapter 1, carbapenem resistant Enterobacteriaceae (suspected or confirmed) must be reported immediately (within 24 hours by email, fax or phone and by ELR if available).
The DHHS HAI program in conjunction with the Nebraska Public Health Laboratory (NPHL) monitors for and investigates CREs in Nebraska.
Number of Carbapenem Resistant Organisms Investigated and Confirmed (Data Chart).
CRE Guidelines and Forms
CRE Outbreak Response Guidelines
CRE Case Investigation Form
CRE Investigation Guidelines
Facility Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE)
For questions about CRE reporting and investigaiton, Contact the HAI Program.
Additional Resources from CDC: